Characteristic | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Year of diagnosis | ||||||
2004–2010 | 1.000 | |||||
2011–2015 | 1.190 | 0.754—1.879 | 0.454 | |||
Age, years | ||||||
< 65 | 1.000 | |||||
≥ 65 | 1.185 | 0.794—1.768 | 0.407 | |||
Sex | ||||||
Male | 1.000 | |||||
Female | 1.190 | 0.762—1.857 | 0.445 | |||
Race | ||||||
White | 1.000 | 0.173 | ||||
Black | 1.829 | 0.971—3.444 | 0.061 | |||
Other | 1.036 | 0.478—2.244 | 0.929 | |||
Tumor grade | ||||||
I | 1.000 | 0.799 | ||||
II | 1.296 | 0.585—2.874 | 0.523 | |||
III | 1.269 | 0.555—2.902 | 0.573 | |||
Other | 0.973 | 0.369—2.566 | 0.956 | |||
Histology | ||||||
SCC | 1.000 | 0.045 | 1.000 | 0.010 | ||
AD | 0.396 | 0.113—0.847 | 0.013 | 0.396 | 0.191—0.821 | 0.013 |
Other | 0.000 | 0.000—1.305 | 0.971 | 0.000 | 0.000—1.563 | 0.971 |
T stage | ||||||
T 1 | 1.000 | 0.057 | 1.000 | 0.125 | ||
T 2 | 1.663 | 0.787—3.512 | 0.183 | 1.608 | 0.756—3.413 | 0.217 |
T 3 | 1.901 | 1.042—3.468 | 0.036 | 1.686 | 0.915—3.108 | 0.094 |
T 4 | 2.253 | 1.272—3.990 | 0.005 | 2.035 | 1.137—3.640 | 0.017 |
N stage | ||||||
N0 | 1.000 | |||||
N1 | 1.155 | 0.735—1.814 | 0.531 | |||
Treatment | ||||||
RS | 1.000 | 1.000 | ||||
CRT | 0.829 | 0.556—1.236 | 0.358 | 0.767 | 0.512—1.149 | 0.198 |